ABVC BioPharma, Inc. (NASDAQ: ABVC) ("ABVC" or the "Company"), a clinical-stage biopharmaceutical company focused on botanical-derived therapeutics and commercial ingredient platforms, today ...
Mr. DePasquale will highlight BIO-key’s growing success in high value sectors including Military & Defense, Finance, Government, and Higher Education, where its unique biometric solutions are solving ...
BIO-key International (BKYI) announced on Wednesday that Nasdaq has flagged the company for non-compliance due to a delay in filing its Q1 2026 Form 10-Q for the period ended March 31, 2026. Nasdaq’s ...
Detailed price information for Bio-Key International Inc (BKYI) from The Globe and Mail including charting and trades.
Earnings Call Insights: BIO-key International, Inc. (BKYI) Q3 2025 DePasquale stated, "we expect continuing deployments in orders even this quarter and beyond" with the large banking customer, ...
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key ...
CommentaryBIO-key CEO, Mike DePasquale commented, “We had a very productive third quarter, with revenue increasing 18% year-over-year and $1M compared to Q2’24, supported by license fee revenue which ...
BIO-key ® International, Inc. (OTC Markets: BKYI), a provider of biometric authentication technologies used by leading military and defense ministries, announced that its CEO Michael DePasquale will ...
HOLMDEL, N.J., May 18, 2026 (GLOBE NEWSWIRE) -- BIO-key ® International, Inc. (OTC Markets: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results